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NEW	  FINDINGS	  
What	  is	  the	  topic	  of	  this	  review?	  
This	   review	   gives	   an	   update	   on	   the	   cellular	   and	  molecular	  mechanisms	  within	   the	  
autonomic	   nervous	   system	   involved	   in	   non-­‐pathological	   and	   pathological	  
cardiovascular	  regulation.	  
What	  advances	  does	  it	  highlight?	  
For	   cardiovascular	   homeostasis	   in	   non-­‐pathological	   conditions	   to	   be	   maintained	  
discrete	  neural	  networks	  utilising	  specified	  signaling	  mechanisms	  at	  both	  cellular	  and	  
molecular	  levels	  are	  required.	  
In	   heart	   failure,	   the	   cell	   signaling	   protein	   partners	   CAPON	   and	   PIN	   decrease	   the	  
bioavailability	  of	  nitric	  oxide	  by	   inhibiting	  neuronal	  nitric	  oxide	  synthase	   leading	   to	  
the	   removal	   of	   tonic	   neuronal	   inhibition.	   	   Following	   a	   myocardial	   infarction,	  
proinflamatory	   cytokines	   in	   the	   paraventricular	   nucleus	   and	   the	   subsequent	  
generation	  of	  reactive	  oxygen	  species,	  via	  angiotensin	  II	  activation	  of	  the	  angiotensin	  
II	   type	   1receptor,	   increase	   neuronal	   exicitability	   further	   leading	   to	   sympathetic	  
excitation.	  
	   3	  
ABSTRACT	  
A	   pathological	   feature	   of	   heart	   failure	   is	   abnormal	   control	   of	   the	   sympathetic	  
nervous	   system.	   The	   paraventricular	   nucleus	   of	   the	   hypothalamus	   (PVN)	   is	   one	   of	  
the	  most	   important	   central	   sites	   involved	   in	   regulating	   sympathetic	   tone	  and	   is,	   in	  
part,	  responsible	  for	  the	  dysregulation	  of	  the	  sympathetic	  nervous	  system	  evident	  in	  
heart	   failure.	   	   Generation	   of	   sympathetic	   tone	   in	   response	   to	   fluctuations	   in	  
cardiovascular	   regulation	   uses	   discrete	   anatomical	   pathways	   and	   neurochemical	  
modulators.	   	  Direct	   and	   indirect	   projections	   from	   the	  PVN	  pre-­‐autonomic	  neurons	  
innervate	   the	   sympathetic	   preganglionic	   neurons	   in	   the	   spinal	   cord,	  which	   in	   turn	  
innervate	   sympathetic	   ganglia	   that	   give	   rise	   to	   the	   sympathetic	   nerves.	   	   Pre-­‐
autonomic	   neurons	   of	   the	   PVN	   themselves	   receive	   afferent	   input	   arising	   from	   the	  
nucleus	   tractus	   solitarii,	   and	   viscerosensory	   receptors	   convey	   cardiovascular	  
fluctuations	   to	   the	   nucleus	   tractus	   solitarii.	   	   The	   PVN	   contains	   excitatory	   and	  
inhibitory	   interneurons,	  whose	  balance	  determines	   the	   sympathetic	   tone.	   	   In	   non-­‐
pathological	   conditions,	   the	   tonic	   inhibition	   of	   the	   PVN	   pre-­‐autonomic	   neurons	   is	  
mediated	  by	  GABA-­‐	  and	  NO-­‐releasing	  neurons.	   	   In	  heart	  failure,	  the	  pre-­‐autonomic	  
neurons	   are	   disinhibited	   by	   the	   actions	   of	   the	   excitatory	   neurotransmitters	  
glutamate	  and	  angiotensin	  II,	  leading	  to	  increased	  sympathetic	  activity.	  A	  key	  feature	  
of	   the	  disinhibition	   is	   a	   reduction	   in	   the	  bioavailability	   of	  NO	  as	   a	   consequence	  of	  
disrupted	  CAPON	  and	  PIN	  signalling	  mechanisms	  within	  the	  neuron.	  	  Another	  critical	  
feature	   that	   contributes	   to	   increased	   neuronal	   excitation	   within	   the	   PVN	   is	   the	  
production	   of	   proinflammatory	   cytokines	   immediately	   following	   a	   myocardial	  
infarction,	  the	  activation	  of	  the	  angiotensin	  II	  type	  1	  receptor	  and	  the	  production	  of	  
reactive	  oxygen	  species.	  By	  examining	  the	  changes	  associated	  with	  the	  sympathetic	  
nervous	   system	   pathway	   we	   will	   progress	   our	   understanding	   of	   sympathetic	  
regulation	   in	   heart	   failure,	   identify	   gaps	   in	   our	   knowledge	   and	   suggest	   new	  
therapeutic	  strategies.	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INTRODUCTION	  
Cardiovascular	   homeostasis	   is	   maintained	   by	   neurohumoral	   integration	   involving	  
both	   the	   neuroendocrine	   and	   autonomic	   nervous	   systems	   (Guyenet,	   2010).	  	  
Processing	   of	   information	   by	   these	   two	   major	   systems	   using	   specific	   neuronal	  
networks	  within	  the	  central	  nervous	  system	  (CNS)	  generates	  adaptive	  neurohumoral	  
responses.	   Neurohumoral	   activation	   is	   also	   seen	   as	   a	   contributor	   to	   numerous	  
diseases	   including	   hypertension	   and	   heart	   failure	   (HF).	   	   Heart	   failure	   can	   be	  
characterised	  by	  neurohumoral	  activation	   in	   response	   to	  decreased	  cardiac	  output	  
and	  under-­‐perfusion	  of	  tissue	  (Watson	  et	  al.,	  2006).	  	  Initially	  in	  the	  short	  term	  these	  
compensatory	   mechanisms	   are	   beneficial	   to	   maintaining	   homeostasis,	   however	  
chronic	  activation	  leads	  to	  further	  deterioration	  in	  heart	  function	  and	  progression	  of	  
the	  HF.	  	  Furthermore,	  the	  increased	  sympathetic	  nerve	  activity	  (SNA)	  inherent	  in	  HF	  
is	  viewed	  as	  a	  major	  contributor	  to	  morbidity	  and	  mortality	  in	  HF	  patients	  (Warion	  et	  
al.,	   2006).	   	   Therefore,	  understanding	   the	  precise	  anatomical	  pathways	  and	  cellular	  
mechanisms	  generating	  the	  increased	  sympathetic	  outflow	  by	  the	  brain	  is	  important	  
physiologically	  and	  clinically	  in	  HF.	  
The	  paraventricular	  nucleus	  (PVN)	  and	  heart	  failure	  
The	   organization	   of	   the	   PVN	   and	   its	   role	   in	   fluid	   balance	   and	   vasopressin	   release	  
make	  the	  PVN	  a	  pivotal	  central	   site	   responsible	   for	  mediating	  sympathetic	  outflow	  
during	   normal	   and	   HF	   states	   (Pyner,	   2009).	   	   Indeed,	   numerous	   studies	   have	  
demonstrated	  that	  there	  is	  increased	  neuronal	  activation	  of	  the	  PVN	  in	  rats	  with	  HF	  
(Li	  &	  Patel,	  2003;	  Han	  et	  al.,	  2010;	  Xu	  et	  al.,	  2012)	  that	  translates	  at	  the	  level	  of	  the	  
end-­‐organ	   as	   increased	   renal	   and	   cardiac	   sympathetic	   nerve	   activity	   (May	   et	   al.,	  
2010).	   	   Of	   the	   neurotransmitters	   localized	   to	   the	   PVN,	   glutamate	   and	   angiotensin	  
(ANGII)	  exert	  excitatory	  effects	  on	  sympathetic	  outflow,	  whereas	  NO	  and	  GABA	  are	  
inhibitory	  mediators	  of	  the	  outflow	  (Li	  &	  Patel,	  2003).	  	  Much	  attention	  has	  been	  paid	  
to	   how	   excitatory	   and	   inhibitory	   transmitter	   interactions	   in	   the	   PVN	   regulate	  
sympathetic	   outflow.	   	   It	   is	   now	   accepted	   that	   a	   down	   regulation	   of	   the	   inhibitory	  
input	   and	   an	   upregulation	   of	   the	   excitatory	   input	   onto	   the	   PVN	   pre-­‐autonomic	  
neruons	  play	  a	  significant	  role	  in	  sympathetic	  dysfunction	  in	  HF.	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Central	  neuronal	  circuitry	  involved	  in	  sympathetic	  regulation	  
The	  PVN,	  the	  rostral	  ventrolateral	  medulla	  (RVLM)	  and	  nucleus	  of	  the	  solitary	  tract	  
(NTS)	  have	  been	  identified	  as	  critical	  sites	  within	  the	  CNS	  that	  regulate	  sympathetic	  
activity	   (Guyenet,	  2006,).	   	   The	  NTS	  provides	   the	  access	   to	   the	  CNS	   for	   information	  
arising	   from	   the	   viscerosensory	   afferents.	   	   From	   this,	   the	   NTS	   then	   initiates	  
adjustments	   in	   reflexes	   that	   maintain	   cardiovascular	   homeostasis	   using	   its	  
connections	   between	   the	   medullary-­‐RVLM	   and	   supramedullary-­‐PVN	   sites	   (Pyner,	  
2009).	  	  The	  PVN	  and	  RVLM	  adjust	  sympathetic	  output	  in	  response	  to	  the	  information	  
forwarded	  by	  the	  NTS	  to	  maintain	  cardiovascular	  homeostasis.	  	  The	  PVN	  and	  RVLM	  
send	  mono-­‐	  and	  polysynaptic	  projections	  to	  the	  sympathetic	  preganglionic	  neurons	  
(SPNs)	   in	   the	   intermediolateral	   cell	   column	   of	   the	   spinal	   cord.	   	   Sympathetic	  
preganglionic	  neurons	  are	  an	  integral	  part	  of	  the	  central	  circuitry	  and	  are	  the	  source	  
of	  all	  sympathetic	  outflow	  to	  every	  organ	  in	  the	  body	  (Figure	  1A;	  Pyner,	  2009).	  
The	  paraventricular	  nucleus	  of	  the	  hypothalamus	  
The	  PVN	  is	  a	  pivotal	  brain	  centre	  involved	  in	  producing	  co-­‐ordinated	  neurohumoral	  
responses	   (Swanson	  &	  Sawchenk,	  1983).	   	  The	  PVN	   is	  a	   functionally	  heterogeneous	  
nucleus	  comprised	  of	  diverse	  groups	  of	  neurons	  (Swanson	  &	  Sawchenko,	  1983).	  	  The	  
main	   groups	   are	   magnocellular,	   which	   synthesise	   vasopressin	   and	   oxytocin	   to	   be	  
released	   from	   the	   posterior	   pituitary	   in	   response	   to	   a	   number	   of	   stimuli	   including	  
hyperosmolarity.	   	   The	   parvocellular	   neuroendocrine	   neurons	   that	   secrete	  
hypophysiotropic	   hormones	   and	   parvocellular	   preautonomic	   neurons	   that	   control	  
sympathetic	   nerve	   activity.	   	   In	   total	   more	   than	   30	   neurotransmitters	   have	   been	  
localized	  to	  neurons	  within	  the	  PVN	  (Stern	  2004;	  Pyner	  2009;)	  
Efferent	  projections	  from	  the	  PVN	  
That	  the	  hypothalamus	  exerts	  an	   important	  regulatory	   influence	  on	  the	  autonomic	  
nervous	  system	  has	  long	  been	  known	  (Bard,	  1928).	  	  We	  now	  know	  the	  parvocellular	  
neurons	  of	  the	  PVN	  are	  reciprocally	  connected	  to	  the	  NTS	  (Swanson	  and	  Sawchenko,	  
1983);	   directly	   project	   and	   terminate	   on	   or	   close	   to	   target	   specified	   SPNs;	   project	  
and	  terminate	  close	  to	  spinally	  projecting	  RVLM	  neurons	  that	  themselves	  terminate	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on	  the	  target	  specified	  SPNs;	  and	  send	  collaterals	  to	  both	  the	  RVLM	  and	  SPNs	  (Pyner	  
2009).	   	   There	  may	  be	   further	  pathways	  we	  have	  yet	   to	   identify.	   	  Activation	  of	   the	  
PVN-­‐RVLM	  and	  PVN-­‐SPN	  pathways	  contribute	  to	  the	  changes	   in	  sympathetic	  nerve	  
activity	  (SNA)	  observed	  after	  activation	  of	  the	  PVN	  and	  stimulation	  of	  the	  PVN	  can	  be	  
correlated	  with	  renal	  SNA	  (Deering	  &	  Coote,	  2000).	  
Afferent	  projections	  to	  the	  PVN	  
Cardiovascular	   afferents	   relaying	   information	   about	   pressure,	   volume	   and	   oxygen	  
saturation	  terminate	  mainly	  within	  the	  NTS	  (Coote,	  2005)	  and	  signals	   from	  each	  of	  
these	   cardiovascular	   sensory	   inputs	   can	   exert	   quiet	   different	   effects	   on	   PVN	  
presympathetic	   neurons.	   	   For	   example,	   arterial	   baroreceptors	   inhibit	  
chemoreceptors	   excite	   and	   venous	   volume	   receptors	   inhibit	   or	   excite	   depending	  
which	  population	   they	   are	   targeting.	   	   Such	   actions	   are	   reflected	   in	   the	  differential	  
responses	  of	  the	  cardiovascular	  target	  organs	  (Coote,	  2005).	  
Connections	   between	  NTS	   and	   the	   PVN	   have	   previously	   been	   described,	   however	  
the	   final	   neuronal	   target	   of	   the	   NTS-­‐PVN	   projecting	  was	   not	   known	   until	   recently	  
(Affleck	  et	  al.,	  2012).	  	  We	  demonstrated	  afferents	  from	  the	  NTS	  target	  at	  least	  four	  
types	   of	   PVN-­‐associated	   neurons:	   presympathetic	   and	   putative	   magnocellular	  
[neuronal	  nitric	  oxide	  synthase	  (n-­‐NOS)-­‐positive]	  lying	  within	  the	  PVN	  and	  GABA	  and	  
nNOS-­‐positive	  neurons	  surrounding	  the	  PVN.	  	  A	  small	  number	  of	  afferent	  projecting	  
boutons	   were	   immunopositive	   for	   the	   vesicular	   glutamate	   transporter	   vGLUT2,	  
suggesting	  glutamate	  as	  neurotransmitter	  candidate	  for	  this	  pathway	  Figure	  1B).	  	  In	  
addition,	   The	   A2	   noradrenergic	   neurons	   in	   the	   NTS	   that	   are	   activated	   by	  
cardiopulmonary	   receptors	   also	   project	   to	   the	   PVN	   indicating	   catecholaminergic	   a	  
projection	  could	  also	  be	  a	  transmitter	  candidate	  (Appleyard	  et	  al.,	  2007;	  Pedrino	  et	  
al.,	  2012).	  	  Thus	  in	  terms	  of	  reflex	  control	  of	  cardiovascular	  regulation	  we	  are	  now	  in	  
a	  position	  to	  link	  the	  sensory	  inputs	  to	  the	  NTS	  with	  specific	  neuronal	  targets	  in	  the	  
PVN	  that	  either	  directly	  or	  indirectly	  regulate	  sympathetic	  activity.	  We	  could	  even	  go	  
as	   far	   as	   to	   speculate	   since,	   baroreceptors,	   chemoreceptors	   and	   atrial	   receptors	  
terminate	  in	  the	  region	  of	  the	  NTS,	  the	  targeted	  PVN	  neurons	  are	  representative	  of	  
the	  reflex	  pathway	  of	  each	  of	  these	  sensory	  receptors.	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Mechanotransduction	  in	  the	  atria	  
Atrial	  volume	  receptors	  embedded	  in	  the	  walls	  of	  the	  atria	  are	  the	  mechanosensors	  
signaling	  plasma	  volume	  fluctuations	  to	  the	  NTS	  via	  the	  vagus	  nerve.	  	  Early	  work	  on	  
the	   dog	   (Kappagoda	   et	   al.,	   1973)	   clearly	   demonstrated	   that	   stimulation	   of	   these	  
receptors	  produces	  a	  reflex	  reduction	  in	  SNA	  at	  the	  level	  of	  the	  kidney.	  	  Later	  studies	  
focusing	   on	   the	   PVN	   in	   the	   rat	   demonstrated	   a	   similar	   renal	   SNA	   effect	  when	   the	  
PVN	  was	  stimulated	  with	  D,L-­‐homocysteic	  acid	  	  (DLH)	  or	  the	  parvocellular	  neurons	  of	  
the	  PVN	  were	  selectively	  lesioned	  with	  kainic	  acid,	  implying	  a	  role	  for	  the	  PVN	  in	  this	  
volume	  reflex	  response	  (Lovick	  et	  al.,	  1993;	  Deering	  &	  Coote,	  2000).	  	  We	  now	  know	  
selective	   stimulation	   of	   the	   right	   atrial	   receptors	   activates	   a	   subset	   of	   PVN-­‐
parvocellular	  neurons	  (Pyner	  et	  al.,	  2002).	  
Atrial	   stretch	   related	   to	   blood	   volume	   return	   is	   transduced	   to	   an	   electrical	   output	  
when	   mechanosensors	   undergo	   mechanical	   deformation.	   	   The	   mechanosensors	  
comprise	   channel	   proteins	   that	   when	   activated	   results	   in	   the	   generation	   of	   the	  
action	   potentials	   (Delmas	   et	   al.,	   2001).	   	   The	   channel	   composition	   for	   atrial	  
mechanosensors	   has	   not	   been	   elucidated.	   	   A	   preliminary	   study	   from	   our	   lab	  
indicates	  the	  transient	  receptor	  potential	  (TRP)	  family	  of	  channels	  TRPC1	  and	  TRPV4	  
may	  be	  expressed	  in	  the	  endothelium	  of	  the	  right	  atria	  of	  rat	  heart	  (Shenton	  et	  al.,	  
2012,	   2013).	   This	   contrasts	   with	   the	   baroreceptor	   and	   muscle	   spindle	   where	  
Epithelial	  Na	  Channel/Degenerin/Acid	  Sensing	  Ion	  Channel	  (ENaC/DEG/ASIC)	  families	  
have	  been	  reported	  (Drummond	  et	  al.,	  1998;	  Simon	  et	  al.,	  2010).	  	  Furthermore,	  we	  
also	  found	  the	  Ca2+-­‐activated	  K+	  channels,	  SK2	  and	  SK4	  in	  this	  region,	  although	  they	  
did	  not	  appear	  to	  be	   located	   in	  putative	  mechanosensitive	  endings	  (Shenton	  et	  al.,	  
2012,	   2013).	   	   Thus,	   the	   volume	   reflex	   arc	   and	   the	   resultant	   sympathetic	   output	  
needs	   channel	   proteins	   and	   the	   anatomical	   pathways.	   	   As	   such	   it	   is	   therefore	  
necessary	   to	   identify	   the	   channel	   proteins	   that	   give	   rise	   to	   the	   mechanosensory	  
properties	   of	   the	   atrial	   volume	   receptor	   and	   the	   nature	   of	   any	   neuromodulator	  
present.	  
Neurotransmission	  
To	   return	   to	   the	   PVN,	   the	   level	   of	   SNA	   is	   dependent	   upon	   the	   integration	   of	  
excitatory-­‐inhibitory	  activation	  of	  the	  preautonomic	  neurons	  by	  the	  GABAergic	  and	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glutamatergic	   interneurons	   that	   surround	   the	   nucleus	   (Biancardi	   et	   al.,	   2010).	  	  
Preautonomic	   neurons	   are	   under	   tonic	   inhibition	   arising	   from	   a	   nitric	   oxide	   (NO)	  
mediated	   GABAergic	   inhibition	   at	   the	   GABAA	   receptor	   (Li	   et	   al.,	   2004).	   	   While	  
excitatory	   activation	   is	   glutamate	   dependent	   via	   the	   NMDA	   receptor,	   in	   the	  
anaesthetised	  rat,	  tonic	  glutamate	  driven	  excitation	   in	  the	  PVN	  does	  not	  appear	  to	  
contribute	   to	   the	   prevailing	   basal	   level	   of	   blood	   pressure	   or	   SNA	   under	   normal	  
conditions	  (Campos	  &	  Bergamaschi,	  2006).	  	  However	  again	  in	  the	  anaesthetized	  rat,	  
when	  SNA	   is	  enhanced	   in	  HF,	   kynurenate	  or	   the	  NMDA	  antagonist	  AP-­‐5	  decreases	  
sympathetic	   drive,	   suggesting	   a	   glutamate	   driven	   excitation	   on	   preautonomic	   PVN	  
neurons	   now	   contributes	   significantly	   to	   the	   level	   of	   SNA	   (Li	   et	   al.,	   2003).	   	   The	  
question	  to	  ask,	  is	  how	  does	  this	  happen?	  
Accumulating	   evidence	   supports	   the	   idea	   that	   a	   down	   regulation	   of	   nNOS,	   the	  
enzyme	  responsible	  for	  the	  production	  of	  constitutively	  expressed	  NO	  generation	  in	  
concert	  with	  altered	  hypothalamic	  GABAergic	   inhibitory	  and	  excitatory	   inputs	  onto	  
the	  preautonomic	  neurons	  contribute	  to	  the	  exacerbated	  sympathetic	  drive	  in	  HF	  (Li	  
et	   al.,	   2006).	   	   Such	   that	   in	   the	  PVN	  of	  HF	   rats,	  GABAA	   receptor	   density	   is	   reduced	  
whereas	  NMDA	  receptor	  density	  remains	  unchanged.	   	  Thus	  the	  down	  regulation	  of	  
the	   GABAergic	   input	   combined	   with	   a	   consistent	   glutamate	   input	   within	   the	   PVN	  
may	  be	  a	  major	  candidate	  that	  determines	  resting	  sympathetic	  vasomotor	  tone	  in	  HF	  
rats	   (Carillo	   et	   al.,	   2012).	   	   The	   contribution	   of	   other	   excitatory	   inputs	   such	   as	  
angiotensin	   II	   (ANGII)	   to	  elevated	  sympathetic	  tone	   in	  HF	  must	  also	  be	  considered.	  	  
Zhu	  et	  al.,	  2004,	  demonstrated	  angiotensin	  II	  type	  1	  receptor	  (AT1-­‐R)	  blockade	  in	  the	  
PVN	  with	  losartan	  reduced	  renal	  SNA	  in	  HF	  rats,	  suggesting	  that	  altered	  AT1-­‐R)	  in	  the	  
PVN	  may	  be	  involved	  in	  elevated	  sympathetic	  tone.	  	  Also	  Li-­‐Fan	  et	  al.,	  2006	  showed	  
using	  an	  in	  vitro	  slice	  preparation	  that	  bath	  application	  of	  bicuculline	  increased	  the	  
frequency	   of	   glutamate-­‐mediated	   excitatory	   postsynaptic	   currents	   in	   a	   PVN-­‐RVLM	  
neuronal	   projection.	   	   The	   changes	   in	   transmitter	   function	   probably	   relates	   to	  
“oxidant	   stress”	   due	   to	   an	   increased	   production	   of	   reactive	   oxygen	   species	   (ROS).	  	  
Reactive	   oxygen	   species	   generation	   is	   a	   normal	   by-­‐product	   of	   cellular	  metabolism	  
and	   is	   usually	   kept	   under	   tight	   control	   by	   antioxidant	   enzymes	   (Zimmerman	   &	  
Davisson,	   2004).	   	   Of	   the	   many	   ROS-­‐genertaing	   enzymes,	   activation	   of	   the	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nicotinamide	   adenine	   dinucleuotide	   phosphate	   (NAD(P)H	   oxidase	   or	   Nox	   enzymes	  
appear	   particularly	   important	   in	   HF	   (Guggilam	   et	   al.,	   2011).	   	   Furthermore,	   an	  
upregulation	   of	   the	   homologue	   Nox4	   in	   the	   PVN	   is	   associated	   with	   sympatho-­‐
excitation	   and	   impaired	   cardiac	   function	   in	   the	   early	   stages	   of	   HF	   (Infanger	   et	   al.,	  
2010).	  	  The	  questions	  remains:	  how	  does	  the	  increased	  Nox-­‐derived	  ROS	  contribute	  
to	   the	   sympatho-­‐excitation	   and	  what	   triggers	   the	  Nox	   to	   produce	  more	  ROS?	   It	   is	  
likely	  that	  the	  production	  of	  ROS	  after	  activation	  of	  the	  AT1-­‐R	  and	  the	  production	  of	  
proinflammmatory	  cytokines	  (PICs)	  play	  a	  major	  part.	  
To	  further	  demonstrate	  the	  crucial	  role	  of	  GABAA	  receptor	  down	  regulation,	  we	  have	  
shown	   in	   the	   spontaneously	   hypertensive	   rat	   (SHR)	   protein	   expression	   and	   PVN-­‐
preautonomic	  neuronal	  expression	  of	  the	  GABAAα	  1	  &	  5	  subunits	  is	  decreased	  whilst	  
the	  GluN2A	  subunit	  of	  the	  NMDA	  receptor	  is	  up	  regulated.	  	  This	  agrees	  with	  Ye	  et	  al.,	  
(2102)	   for	   the	   SHR	   who	   demonstrated	   not	   only	   GluN2A	   but	   also	   GluN2B	   subunit	  
regulation	  when	  compared	  to	  age	  matched	  Wistar	  Kyoto	  controls.	  	  We	  interpret	  this	  
as	   the	   association	   of	   GABAA	   and	   NMDA	   receptor	   subunit	   with	   PVN-­‐preautonomic	  
neurons	  providing	  a	  mechanism	  by	  which	  the	  discharge	  properties	  of	  the	  neuron	  can	  
be	  regulated	  to	  determine	  sympathetic	  output.	  	  Therefore,	  any	  switch	  in	  the	  subunit	  
of	   the	   receptor	  has	   the	  potential	   to	   influence	   the	  discharge	  of	   the	  presympathetic	  
neurons	  (Cork	  et	  al.,	  2012,2013).	  	  Interstingly,	  Li	  et	  al.,	  (2003)	  reported	  an	  increase	  in	  
NR1	  subunit	  regulation	  but	  no	  change	   in	  NR2	  I	  HF	  rats.	   	  An	  obvious	  explanation	  to	  
the	   discrepancies	   relates	   to	   animal	  model	   selection	   i.e.	   HF	   vs	   hypertension	  would	  
argue	   that	   the	   mechanisms	   producing	   the	   sympatho-­‐excitation	   is	   related	   to	   the	  





Our	  wealth	  of	  knowledge	  about	  the	  neural	  control	  of	  HF	  has	   increased	  but	  we	  still	  
have	  very	   little	  clues	   to	  origins	  or	   instigator(s)	  and	  cellular	  signaling	  processes	   that	  
might	  be	  possible	  drug	  targets.	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Cellular	  signaling	  –Nitric	  Oxide	  
While	   gross	   changes	   in	   neurotransmitter	   availability	   and	   receptor	   subunit	  
conformational	   changes	   can	   be	   shown	   to	   alter	   the	   electrical	   properties	   of	   the	  
preautonomic	   neuron,	   the	   cellular	   signalling	   mechanisms	   leading	   to	   the	   gross	  
changes	  are	  lacking.	  It	  is	  probably	  an	  alteration	  of	  these	  that	  give	  rise	  to	  the	  chronic	  
long-­‐term	  impact	  on	  the	  overall	  level	  of	  neuronal	  excitability.	  
Most	   research	  has	   focused	  on	   the	  cell	   signaling	   related	   to	  NO.	   	  The	  activity	  of	   the	  
nNOS	  ,	  the	  enzyme	  responsible	  for	  NO	  production,	  is	  highly	  controlled	  and	  is	  subject	  
to	  transcriptional,	  translational	  and	  post-­‐translational	  regulation,	  which	  dictates	  the	  
specificity	   of	   NO	   signaling	   and	   limits	   NO	   toxicity	   (Alderton	   et	   al.,	   2001).	   	   Post-­‐
translational	   controls	   include	   protein-­‐protein	   interactions.	   The	   protein	   partners	  
CAPON	  (carboxy-­‐terminal	  PDZ	  ligand-­‐PSD-­‐95/Discs	  large/zona	  occludens-­‐1	  of	  nNOS)	  
and	  PIN	   (protein	   inhibitor	  of	  nNOS)	   interact	  with	  nNOS	  specifically	   through	   its	  PDZ	  
and	  PIN	  binding	  domains,	  respectively.	  	  CAPON	  binding	  can	  restrict	  NO	  generation	  by	  
competing	  with	   the	  polysynaptic	  density	  protein	  PSD95	   for	   interaction	  with	  nNOS.	  	  
In	   HF,	   nNOS	   expression	   decreases	   via	   post-­‐translational	   modification	   through	   an	  
ANGII-­‐mediated	   enhanced	   expression	   of	   PIN.	   	   Angiotensin	   II	   acting	   via	   AT1-­‐R	  
upregulates	  PIN	  expression	  with	  a	  concomitant	  decrease	  in	  the	  expression	  of	  nNOS	  
(Figure	  2A;	  Sharma	  et	  al.,	  2013.	  	  The	  action	  of	  ANGII	  at	  the	  AT1-­‐R	  is	  upregulated	  in	  
HF.	  	  Angiotensin	  II	  stimulation	  of	  the	  AT1-­‐R	  potentiates	  neuronal	  excitability	  and	  this	  
effect	   is	   constrained	   by	   a	   NO-­‐GABAergic	   feedback	   system	   that	   suppresses	   AT1-­‐R	  
activation	  (Li	  et	  al.,	  2003).	  	  In	  HF,	  the	  inhibitory	  modulation	  of	  the	  AT1-­‐R	  is	  reduced	  
and	   this	   may	   upregulate	   PIN	   expression	   in	   the	   PVN	   inhibiting	   nNOS	   activity	   the	  
subsequent	  production	  of	  NO	  and	  removal	  of	  tonic	  neuronal	   inhibition.	  The	  role	  of	  
PIN	  on	  glutamate	  and	  GABA	  is	  indirect	  via	  its	  actions	  on	  nNOS.	  
In	   the	  brain	  NO	  biosynthesis	   depends	  on	   the	   availability	   of	   the	  NOS	   cofactors,	   for	  
example	   (6R)-­‐5,6,7,8-­‐tetrahydrobiopterin	   (BH4)	   as	   well	   as	   NAD(P)H	   as	   an	   electron	  
source.	   	   Homodimerisation	   and	   cofactor	   binding	   are	   critical	   for	   the	   enzymatic	  
activity	  of	  nNOS.	  	  The	  dimerization	  of	  nNOS	  is	  promoted	  by	  heme	  incorporation	  and	  
BH4	  is	  required	  to	  stabilize	  the	  nNOS	  dimer	  once	  it	  is	  formed	  (Alderton	  et	  al.,	  2001).	  	  
Neuronal	   nitric	   oxide	   activation	   without	   proper	   BH4	   binding	   uncouples	   normal	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electron	   transfer	   to	  produce	  superoxide.	   	   In	  HF,	  BH4	  bioavailability	   is	  known	  to	  be	  
impaired	  in	  endothelial	  cells	  but	  there	  is	  no	  evidence	  for	  reduced	  BH4	  bioavailability	  
in	  the	  PVN	  (Schmidt	  &	  Alp,	  2007).	  	  Thus	  the	  role	  of	  NOS	  cofactors	  in	  nNOS	  regulation	  
in	  HF	  remains	  to	  be	  elucidated.	  
Cytokines	  and	  superoxide	  
In	  HF,	  apart	  from	  activation	  of	  neurohormones	  there	  is	  also	  activation	  of	  PICs	  such	  as	  
tumor	  necrosis	  factor	  (TNF),	   interleukin	  (IL)-­‐1β	  and	  IL-­‐6	   in	  the	  PVN	  and	  the	  level	  of	  
circulating	  cytokines	  correlates	  with	  deteriorating	  HF	  (Francis	  et	  al.,	  2004).	  
Following	  an	  acute	  myocardial	  infarction	  (MI)	  elevated	  PICs	  are	  transported	  into	  the	  
hypothalamus	   and	   brainstem	   via	   the	   circumventricular	   organs	   and	  within	  minutes	  
TNF	  is	  observed	  in	  the	  brain	  (Francis	  et	  al.,	  2004).	  	  Circulating	  ANGII	  and	  PICS	  are	  also	  
major	  activators	  of	  microglial	  cells,	  astrocytes	  and	  macrophages,	  which	  consequently	  
produce	  more	  PICs	  (Shi	  et	  al.,	  2013).	  	  The	  PICs	  are	  distributed	  particularly	  in	  the	  PVN	  
and	  medulla,	  sites	  that	  regulate	  SNA	  to	  various	  cardiovascular	  and	  fluid	  homeostatic	  
organ	  systems	  (Guggilam	  et	  al.,	  2011).	  
Intracerebroventricular	  administration	  of	  ANGII	  increases	  the	  production	  of	  reactive	  
ROS	  (Zimmerman	  et	  al.,	  2002).	   	  Angitoensin	   	   II	   type	  1receptor	  blockade	  in	  the	  PVN	  
and	  RVLM	  attenuates	  ROS	  generation	  contributing	  to	  decreased	  SNA	   in	  HF	  (Han	  et	  
al.,	  2007).	  	  In	  addition,	  previous	  investigations	  have	  shown	  that	  in	  HF,	  the	  increase	  in	  
TNF	  in	  the	  PVN	  is	  associated	  with	  elevated	  expression	  of	  NAD(P)H	  oxidase	  subunits,	  
the	  primary	  source	  of	  super	  oxide	  anions	  (O2.-­‐)	  and	  intimately	  involves	  the	  actions	  of	  
the	   renin-­‐angiotensin	   system	   (Guggilam	  et	   al.,	   2011).	   	  Moreover,	   blockade	  of	   PVN	  
O2.-­‐	   completely	   abolishes	   the	   increased	  SNA	  observed	   in	  HF	   (Figure	  2B;	  Han	  et	   al.,	  
2007).	  
Neuro-­‐glial	  signalling	  
One	  final	  aspect	  to	  consider	  is	  the	  bidirectional	  neuro-­‐glial	  signaling	  in	  neurohumoral	  
regulation	  in	  the	  PVN.	  	  A	  number	  of	  mechanisms	  have	  been	  described	  and	  succinctly	  
summarized	  in	  a	  recent	  review	  by	  Stern	  &	  Filosa	  (2013).	  	  Microglia	  respond	  to	  injury	  
and	  pathogen	  infection	  in	  the	  brain,	  turning	  into	  an	  activated	  pro-­‐inflammatory	  state.	  	  
Active	   microglia	   release	   a	   variety	   of	   pro-­‐inflammatory	   and	   also	   neuroactive	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substances,	  including	  cytokines,	  chemokines,	  ROS	  and	  NO,	  among	  others	  leading	  to	  
exacerbated	  neuronal	  activity	  and	  ultimately	  neuronal	  cell	  death.	  	  Importantly,	  there	  
is	  a	  growing	  body	  of	  evidence	  suggesting	  cardiovascular-­‐related	  signals	  in	  particular	  
ANGII	  can	  lead	  to	  microglial	  activation	  (Stern	  &	  Filosa,	  2013),	  contributing	  in	  turn	  to	  
exacerbated	  neurohumoral	  activation	  in	  disease	  conditions	  such	  as	  HF,	  hypertension	  
and	  diabetes	  (Guggilam	  et	  al.,	  2011).	  
Conclusion	  
Despite	  a	  wealth	  of	  studies	  over	  the	  last	  couple	  of	  decades	  providing	  major	  insights	  
into	   autonomic	   control,	   we	   still	   have	   significant	   gaps	   in	   our	   knowledge.	   It	   would	  
appear	   there	   are	   some	   common	   neuroactive	   substances,	   PICs,	   ROS	   and	   NO	   that	  
affect	  cellular	  and	  molecular	  system.	  	  We	  can	  describe	  the	  contribution	  each	  makes	  
individually	   to	   disrupt	   neuronal	   excitability	   but	   have	   very	   little	   insight	   about	  
interaction	  and	  what	  seems	  crucially	  important	  the	  sequence	  of	  events	  and	  a	  trigger.	  	  
The	  importance	  of	  this	  probably	  lies	  within	  devising	  new	  treatments	  that	  might	  show	  
distinct	  pharmacological	  characteristics	  depending	  on	  the	  stage	  of	  progression	  of	  the	  
HF.
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Schematics	  to	  show	  the	  components	  of	  the	  volume	  reflex	  arc.	  	  Volume	  receptors	  in	  
the	  heart	   (A)	  provide	  the	  afferent	  signals	   to	  the	  NTS,	  which	  are	  then	  conducted	  to	  
the	  PVN.	   	  Direct	  and	   indirect	  efferent	  projections	   influence	  sympathetic	  outflow	  at	  
the	  level	  of	  the	  SPN.	  	  At	  least	  four	  ascending	  pathways	  (B)	  from	  the	  NTS	  target	  PVN	  
neurons	   that	   are	   associated	   with	   cardiovascular	   control:	   (1)	   spinally	   projecting	  
neurons.	   (2)	   nNOS-­‐containing	   magnocellular	   neurons.	   (3)	   GABAergic	   interneurons	  
that	  contact	  spinally	  projecting	  neurons.	  (4)	  nNOS-­‐containing	  interneurons	  bordering	  
the	  PVN.	  	  A	  provided	  by	  G	  Watson	  and	  B	  modified	  from	  Affleck	  et	  al.,	  2012.	  
	  
Figure	  2	  
Schematic	   summaries	   proposing	   how	   alteration	   of	   signaling	   pathways	   can	   lead	   to	  
abnormal	   sympathoexcitation.	   	   Postranslational	   modification	   of	   nNOS	   alters	   the	  
regulation	   of	   the	   PVN	   in	   HF.	   	   Over	   activation	   of	   the	   AT1	   receptor	   leads	   to	   over-­‐
expression	   of	   CAPON	   and	   PIN.	   	   CAPON	   and	   PIN	   interfere	   with	   nNOS	   activation	  
reducing	  NO	  production	  in	  the	  PVN	  causing	  an	  increase	  in	  SNA.	  	  Ischaemic	  injury	  (B)	  
releases	   PICs.	   	   The	   PICs	   signal	   to	   the	   PVN	   causing	   the	   release	   of	   further	   PICs	   and	  
neuorhormones	   leading	   to	   the	   imbalance	   of	   superoxide	   and	   NO	   and	  
sympathoexcitation.	   	   A	   modified	   from	   Sharma	   et	   al.,	   2013	   and	   B	   modified	   from	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